Blueshift Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Buy
+3,165
New +$324K 0.07% 370
2025
Q2
– Sell
-2,769
Closed -$232K – 535
2025
Q1
$232K Buy
+2,769
New +$258K 0.09% 321

Other funds holding LMAT

Blueshift Asset Management's LMAT Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 3,165 shares worth $304K. The stake represents 0.07% of the portfolio and ranks #370 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in LMAT as recently as Q1 2025.

Blueshift Asset Management first reported a position in LMAT in Q1 2025 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Blueshift Asset Management held 3,165 shares of LeMaitre Vascular worth $304K as of Q2 2026.
  • LeMaitre Vascular was a new Blueshift Asset Management position in Q2 2026.
  • LeMaitre Vascular made up 0.07% of Blueshift Asset Management's portfolio in Q2 2026, its #370 holding.
  • Blueshift Asset Management first reported a position in LeMaitre Vascular in Q1 2025 and has held it in 2 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.